UBS Maintains a 'Buy' on Biogen (BIIB); Core Franchise Support Valuation; Pipeline Provides Upside Risk
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $209.83 -0.39%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on Biogen (NASDAQ: BIIB) price target raised from $135 to $148.
Analyst, Matthew Roden, said, "On the basis of our diligence on both the hemophilia and ALS markets, we are raising our Biogen PT to $148. We are formally adding risk-adjusted hemophilia sales to our model on our increased confidence in the ph3 program (A-LONG and B-LONG). We also add dexpramipexole (dex) to our upside scenario, which is not part of our model but impacts our PT via probability-weighting."
Roden cuts FY13 EPS estimate from $7.16 to $7.10.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $132.93 yesterday.
Analyst, Matthew Roden, said, "On the basis of our diligence on both the hemophilia and ALS markets, we are raising our Biogen PT to $148. We are formally adding risk-adjusted hemophilia sales to our model on our increased confidence in the ph3 program (A-LONG and B-LONG). We also add dexpramipexole (dex) to our upside scenario, which is not part of our model but impacts our PT via probability-weighting."
Roden cuts FY13 EPS estimate from $7.16 to $7.10.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $132.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
- Raymond James Downgrades Accelerant Holdings (ARX) to Market Perform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
